Editorials:

WA Colburn

Products approved for marketing during 1998
J Clin Pharmacol 1999 39: 439. [PDF]  

Articles:

CM White

A review of potential cardiovascular uses of intravenous glucagon administration
J Clin Pharmacol 1999 39: 442. [Abstract] [PDF]  

CW Ogle

Smoking and gastric ulcers: the possible role of nicotine
J Clin Pharmacol 1999 39: 448. [PDF]  

R Loebstein, G Atanackovic, R Bishai, J Wolpin, S Khattak, G Hashemi, M Gobrial, S Baruchel, S Ito, and G Koren

Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children
J Clin Pharmacol 1999 39: 454. [Abstract] [PDF]  

K Umemura, K Kondo, Y Ikeda, M Nishimoto, Y Hiraga, Y Yoshida, and M Nakashima

Pharmacokinetics and safety of Z-321, a novel specific orally active prolyl endopeptidase inhibitor, in healthy male volunteers
J Clin Pharmacol 1999 39: 462. [Abstract] [PDF]  

AA Taylor, R Mangoo-Karim, KD Ballard, RR Luther, and JL Pool

Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study
J Clin Pharmacol 1999 39: 471. [Abstract] [PDF]  

A Le Liboux, JP Cachia, S Kirkesseli, JY Gautier, C Guimart, G Montay, PA Peeters, E Groen, JH Jonkman, and J Wemer

A comparison of the pharmacokinetics and tolerability of riluzole after repeat dose administration in healthy elderly and young volunteers
J Clin Pharmacol 1999 39: 480. [Abstract] [PDF]  

JQ Tran, SJ Kovacs, TS McIntosh, HM Davis, and DE Martin

Morning spot and 24-hour urinary 6 beta-hydroxycortisol to cortisol ratios: intraindividual variability and correlation under basal conditions and conditions of CYP 3A4 induction
J Clin Pharmacol 1999 39: 487. [Abstract] [PDF]  

A Van Hecken, M Depre, R Verbesselt, K Wynants, I De Lepeleire, J Arnout, PH Wong, A Freeman, S Holland, B Gertz, and PJ De Schepper

Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers
J Clin Pharmacol 1999 39: 495. [Abstract] [PDF]  

PH Siedlik, SC Olson, BB Yang, and RH Stern

Erythromycin coadministration increases plasma atorvastatin concentrations
J Clin Pharmacol 1999 39: 501. [Abstract] [PDF]  

D Jung, MH AbdelHameed, P Teitelbaum, A Dorr, and K Griffy

The pharmacokinetics and safety profile of oral ganciclovir combined with zalcitabine or stavudine in asymptomatic HIV- and CMV-seropositive patients
J Clin Pharmacol 1999 39: 505. [Abstract] [PDF]  

JQ Tran, RA Di Cicco, SB Sheth, M Tucci, L Peng, DK Jorkasky, MJ Hursting, and LJ Benincosa

Assessment of the potential pharmacokinetic and pharmacodynamic interactions between erythromycin and argatroban
J Clin Pharmacol 1999 39: 513. [Abstract] [PDF]  

DE Kellstein, JA Waksman, SA Furey, G Binstok, and SA Cooper

The safety profile of nonprescription ibuprofen in multiple-dose use: a meta-analysis
J Clin Pharmacol 1999 39: 520. [Abstract] [PDF]  

DF Lehmann, A Liu, N Newman, and DC Blair

The association of opportunistic infections with the occurrence of trimethoprim/sulfamethoxazole hypersensitivity in patients infected with human immunodeficiency virus
J Clin Pharmacol 1999 39: 533. [Abstract] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.